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ABSTRACT
We report the case of a man in his 70s who suffered 
from intestinal infarction caused by acute portal vein 
and mesenteric vein thrombosis (PVMVT). Combina-
tion therapy with percutaneous transcatheter throm-
bectomy and surgical bowel resection was successfully 
performed, and a satisfactory outcome was achieved. 
Intestinal infarction caused by PVMVT can be fatal 
and has a high mortality rate even if surgical resection 
is performed. The combination therapy of intervention-
al radiology and surgery might be a safe and effective 
method for patients with this life-threatening condition.
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Acute portal vein and mesenteric vein thrombosis 
(PVMVT) is a rare and insidious disease that is associ-
ated with significant mortality and morbidity. Its clinical 
manifestations are often asymptomatic or nonspecific, 
such as nausea, anorexia, and abdominal distension. 
Thus, the diagnosis of PVMVT is frequently delayed, 
which can be fatal owing to complications such as mes-
enteric ischemia and infarction with multiorgan failure. 
In patients with PVMVT-related intestinal infarction, 
the mortality rate has been reported to be 37–76%.4 
Therefore, early accurate diagnosis is very important. 
The traditional management of this condition has been 
anticoagulation therapy. Surgery is reserved for patients 
who have failed anticoagulation therapy or for those who 
present with signs of mesenteric ischemia and infarction. 
Due to recent advances in catheter-directed treatment, 
interventional radiology (IR) such as the percutaneous 
transhepatic technique has been recognized as an al-
ternative, less invasive option with minimal complica-
tions.1–8 However, despite previous reports, a reliable 
therapeutic strategy for PVMVT-related with intestinal 
infarction is yet to be established.
 We report here a case of PVMVT-related intestinal 
infarction that was successfully treated with a combina-
tion therapy of IR and surgical resection.
PATIENT REPORT
A man in his 70s with no significant medical history 
was hospitalized in the emergency department because 
of abdominal pain and bloody stool persisting for 4 days. 
On physical examination, abdominal rebound tender-
ness was found. Initial laboratory test results revealed a 
white blood cell count of 13100/μL and a C-reactive pro-
tein level of 2.41 mg/L. Abdominal enhanced computed 
tomography (CT) revealed extensive necrosis of the 
terminal ileum and continuous thrombus from the ileal 
branches via the superior mesenteric vein (SMV) to the 
main trunk of the portal vein (PV, Fig. 1). The condition 
was diagnosed as ileal necrosis due to venous thrombo-
sis, and the combined treatment of IR and surgery was 
administered immediately.
 First IR procedure: Under local anesthesia, using 
ultrasonographic guidance, percutaneous transhepatic 
access to the left portal vein was established and a 5-Fr 
vascular sheath was inserted. Direct portography re-
vealed occlusion with extensive thrombosis from the il-
eal branches up to the main trunk of the PV. The throm-
bosed PV and SMV were passed through by a 0.035-inch 
guidewire, and catheter-directed thrombolysis was per-
formed after injecting a high dose of urokinase (120000 
units, Uronase; Mochida, Tokyo, Japan) via a pulse-
spray catheter (Fountain; Merit Medical, South Jordan, 
UT; Figs. 2A and B). 
 Laparotomy: In the laparotomy performed imme-
diately after the first IR procedure, infarction of the ter-
minal ileum was recognized and approximately 50 cm 
of the small intestine was resected. Despite the presence 
of a large venous thrombus, surgical thrombectomy was 
not performed. At the completion of surgery, intravenous 
heparin infusion was maintained at the rate of 1000 
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Fig. 1. First dynamic CT. (A) Initial CT shows intraluminal thrombosis in the PV and the mesenteric vein (arrow). (B) Jejunal loop dilata-
tion and diffuse wall thickening with ascites are evident (arrow head). CT, computed tomography; PV, portal vein.
Fig. 2. Percutaneous transhepatic portography shows thrombus in 
the portal vein trunk (arrow) extending to the mesenteric vein. 
Fig. 3. Direct portography at the second and third IR sessions 
reveal residual thrombus in the PV and SMV. Percutaneous 
transhepatic thrombectomy, thrombolysis, and angioplasty were 
performed. IR, interventional radiology; PV, portal vein; SMV, 
superior mesenteric vein.
units per hour. 
 Second and third IR procedures: Transcatheter 
thrombectomy for the residual thrombus was performed 
on day 1 and 2 after the operation as the second and 
third IR procedure, respectively. Manual aspiration 
thrombectomy was performed using a 6-Fr guiding 
catheter (Launcher; Medtronic, Minneapolis, MN). Di-
rect thrombolysis was performed using 120000 units of 
urokinase. Angioplasty was performed using a balloon 
catheter of 8 mm diameter and 4 cm length (Mustang; 
Boston Scientific, Natick, MA). At the completion of 
IR therapy, urokinase administration (5000 units/hour) 
was continued for an additional 48 hours via the catheter 
placed in the SMV (Fig. 3). 
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 Follow-up: Four days after the operation, sufficient 
blood flow and recanalization of the SMV and PV were 
confirmed by portography (Fig. 4). Follow-up CT per-
formed 9 days after the first IR procedure revealed only 
a small amount of remnant thrombus in the SMV and 
PV (Fig. 5). No adverse event or complication occurred, 
and the patient was discharged on day 24 of hospitaliza-
tion. He was followed up in the outpatient department 
with performing anticoagulant therapy using warfarin, 
and no complication was noted.
DISCUSSION
PVMVT is a relatively rare disease with an incidence 
of approximately 5–15% among mesenteric ischemic 
events.1, 2 Myeloproliferative disease, intraabdominal in-
fections or inflammations, septicemia, cirrhosis, intraab-
dominal surgery, trauma, hypercoagulable states (insuf-
ficiency of antithrombin III, protein C, protein S, etc.), 
oral contraceptives use, and liver tumors are the most 
common causes for PVMVT.3 However, our patient had 
none of these risk factors and the cause of thrombosis 
was not identified despite elaborate examinations.
 The main goals of therapy for acute PVMVT are 
preventing extension of the thrombus, recanalization of 
the vessels in the short term, and preventing recurrence in 
the long term. Anticoagulation is the initial approach in 
management. Acute PVMVT without bowel ischemia has 
traditionally been treated using systemic anticoagulation 
therapy with heparin and warfarin to prevent propagation 
of the thrombus and recanalize the occluded vessels. How-
ever, for patients with intestinal infarction, perforation, 
and peritonitis, emergency laparotomy with bowel resec-
tion may be essential and warranted for survival. Bowel 
resection and anastomosis are the standard procedures 
performed with the goal of conserving as much of the 
bowel as possible. In previous case series of PVMVT-re-
lated intestinal infarction, the average length of resected 
bowel has been 50–60 cm, which is as same as our base. 
Moreover, these series reported high mortality (37–76%) 
and high recurrence rates (11–29%).2, 4, 6, 7 Here, we as-
sumed that mortality and recurrence rate were associated 
with the volume of the resected intestine. Moreover, our 
patient had an extensive thrombosis extending from the 
ileal branches up to the main trunk of the PV. Hence, 
sufficient surgical thrombectomy was considered haz-
ardous as it comes with a high risk of critical bleeding. 
Taking these factors into consideration, we employed an 
endovascular approach simultaneously with a surgical 
approach to recanalize the thrombosed vein consider-
ably and reduce the volume of bowel resection.
 Endovascular therapy for PVMVT has been recog-
nized as a therapeutic alternative that is minimally inva-
sive and has a relatively low mortality. In a retrospective 
study of 20 PVMVT patients with or without intestinal 
infarction who were treated with thrombolysis via the 
transhepatic route and/or superior mesenteric artery 
route, 75% experienced partial or complete clot reso-
Fig. 5. Follow-up abdominal CT at day 10 after IR and surgery 
shows only a small amount of remnant thrombus in the PV and 
SMV (arrow). CT, computed tomography; IR, interventional ra-
diology; PV, portal vein; SMV, superior mesenteric vein. 
Fig. 4. Portography performed 4 days after IR procedure and sur-
gery shows recanalization and antegrade hepatopetal flow in the 
SMV and PV. IR, interventional radiology; PV, portal vein; SMV, 
superior mesenteric vein.
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lution and 85% experienced resolution of symptoms.8 
The ratio of a bleeding complication is not so high as 
0.06–15% in the previous reports.9–12 In the present case, 
we performed percutaneous transhepatic thrombolysis, 
thrombectomy, and angioplasty, which permits access to 
the PV and SMV system and thus allows for infusion of 
thrombolytic agents directly into the occluded vein with 
a limited amount of lytic agents and for longer dura-
tions.2, 3 Using this method, recanalization from the ileal 
branch up to the PV was achieved safely, and adequate 
blood circulation was maintained without any adverse 
events. Moreover, the length of the resected intestine 
was limited to 50 cm, and thrombosis or bowel ischemia 
did not recur.
 To the best of our knowledge, till date, no report has 
indicated the efficacy of combination therapy of IR and 
surgical resection for PVMVT-related intestinal infarc-
tion. Percutaneous transhepatic thrombolysis, thrombec-
tomy, and angioplasty with surgical resection are valid 
strategies for recanalization, and they may be effective 
in reducing the mortality rate of patients with PVM-
VT-related intestinal infarction. 
 In conclusion, acute PVMVT-related intestinal in-
farction is a rare disease with high mortality; hence, ear-
ly diagnosis and treatment are essential. We successfully 
saved this life-threatening case with the combination 
therapy of IR and surgical resection.
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